Across TCGA pan-cancer cohorts, STAU2P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of STAU2P1’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where STAU2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types STAU2P1 is over-expressed in tumor.
LUAD and HNSC are the cancer types where STAU2P1 tumor–normal differential expression is most reproducible.